246 results
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... lung disease (ILD ... #lungdisease #ILD ... #indications #management ... #treatment #algorithm
Lupus Nephritis Primer
Class I - Minimal Mesangial
Class II - Mesangial Proliferative
Class Ill - Focal Proliferative
Class IV
Proliferative Class Ill ... Lupus #Nephritis #SLE ... differential #diagnosis #management ... #nephrology
Management of Lupus Nephritis
Lupus nephritis (LN) in 10 to 40% of SLE
Hallmark = proteinuria 20.5 g/g
Management of Lupus ... proliferative LN • Class Ill ... : active Ill ... chronic lesions Ill ... #rheumatology #nephrology
Algorithmic Approach to the Patient with Azotemia

#Azotemia #AKI #Nephrology #Diagnosis #Differential #Algorithm #Management
Algorithmic Approach ... Azotemia #AKI #Nephrology ... #Differential #Algorithm ... #Management
Central Distribution, Febrile / Ill:
 - Viral Exanthem 
 - Lyme Disease (erythema migrans) 
Central Distribution,
Distribution, Febrile / Ill ... Afebrile, non-ill ... Afebrile / non-ill ... Afebrile / non-ill ... Papules #Rash #Algorithm
Intravenous Lipid Emulsion (ILE) Therapy

ILE is a treatment for severe toxicity from local anesthetics. In addition,
Lipid Emulsion (ILE ... ) Therapy ILE ... Lipid #Emulsion #ILE ... Therapy #Toxicology #Management
Main causes of diffuse parenchymal lung diseases.

#differential #algorithm #diagnosis #causes #DPLD #ILD #parenchymal #lung #diseases #pulmonary
#differential #algorithm ... #causes #DPLD #ILD
Recommendations for initial management of Unstable Angina/NSTEMI

Flowchart for class I and class lla recommendations for initial
Recommendations for initial management ... bypass grafting; GP Ilb ... , glycoprotein Ilb ... UnstableAngina #Management ... #Algorithm #Cardiology
Diagnostic algorithm for idiopathic pulmonary fibrosis, in part adapted from the ATS/ERS consensus statement. HRCT =
Diagnostic algorithm ... computerised tomography; ILD ... #IPF #UIP #Algorithm
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Anti-IL6 Agents ... in COVID19 IL ... Activation Syndrome” IL ... kg IV x1 (anti-IL6 ... #Pharmacology #Management